162 related articles for article (PubMed ID: 26006306)
21. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
[TBL] [Abstract][Full Text] [Related]
22. Striking the Optimal Solubility-Permeability Balance in Oral Formulation Development for Lipophilic Drugs: Maximizing Carbamazepine Blood Levels.
Beig A; Miller JM; Lindley D; Dahan A
Mol Pharm; 2017 Jan; 14(1):319-327. PubMed ID: 27981848
[TBL] [Abstract][Full Text] [Related]
23. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
[TBL] [Abstract][Full Text] [Related]
24. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.
Nogueiras-Nieto L; Sobarzo-Sánchez E; Gómez-Amoza JL; Otero-Espinar FJ
Eur J Pharm Biopharm; 2012 Apr; 80(3):585-95. PubMed ID: 22182528
[TBL] [Abstract][Full Text] [Related]
25. Study on the intestinal absorption profiles of tanshinone IIA and its inclusion complex with cyclodextrin in rats.
Wang L; Lai Y; Li C; Jiang X
PDA J Pharm Sci Technol; 2009; 63(5):390-400. PubMed ID: 20158045
[TBL] [Abstract][Full Text] [Related]
26. Artemether/hydroxypropyl-beta-cyclodextrin host-guest system: characterization, phase-solubility and inclusion mode.
Yang B; Lin J; Chen Y; Liu Y
Bioorg Med Chem; 2009 Sep; 17(17):6311-7. PubMed ID: 19665897
[TBL] [Abstract][Full Text] [Related]
27. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
[TBL] [Abstract][Full Text] [Related]
28. Methyl-beta-cyclodextrins: the role of number and types of substituents in solubilizing power.
Fenyvesi É; Szemán J; Csabai K; Malanga M; Szente L
J Pharm Sci; 2014 May; 103(5):1443-52. PubMed ID: 24590624
[TBL] [Abstract][Full Text] [Related]
29. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
30. Influence of sulfobutyl ether beta-cyclodextrin (Captisol) on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion.
Fukuda M; Miller DA; Peppas NA; McGinity JW
Int J Pharm; 2008 Feb; 350(1-2):188-96. PubMed ID: 17920217
[TBL] [Abstract][Full Text] [Related]
31. Supramolecular interactions between losartan and hydroxypropyl-β-CD: ESI mass-spectrometry, NMR techniques, phase solubility, isothermal titration calorimetry and anti-hypertensive studies.
de Paula WX; Denadai AM; Santoro MM; Braga AN; Santos RA; Sinisterra RD
Int J Pharm; 2011 Feb; 404(1-2):116-23. PubMed ID: 21093554
[TBL] [Abstract][Full Text] [Related]
32. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
33. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
[TBL] [Abstract][Full Text] [Related]
34. Lack of effect of beta-cyclodextrin and its water-soluble derivatives on in vitro drug transport across rat intestinal epithelium.
Zheng Y; Zuo Z; Chow AH
Int J Pharm; 2006 Feb; 309(1-2):123-8. PubMed ID: 16359834
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state.
Jug M; Mennini N; Kövér KE; Mura P
J Pharm Biomed Anal; 2014 Mar; 91():81-91. PubMed ID: 24444785
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers.
Nie S; Zhang S; Pan W; Liu Y
Drug Dev Ind Pharm; 2011 May; 37(5):606-12. PubMed ID: 21469949
[TBL] [Abstract][Full Text] [Related]
37. Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: the effect of PEG-400 on carbamazepine absorption.
Beig A; Miller JM; Dahan A
Eur J Pharm Biopharm; 2012 Jun; 81(2):386-91. PubMed ID: 22387337
[TBL] [Abstract][Full Text] [Related]
38. Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.
Jug M; Bećirević-Laćan M; Cetina-Cizmek B; Horvat M
Pharmazie; 2004 Sep; 59(9):686-91. PubMed ID: 15497750
[TBL] [Abstract][Full Text] [Related]
39. In Vitro Dissolution Studies of Amiodarone Hydrochloride From Hydroxy-Propyl-β-Cyclodextrin/Amiodarone Inclusion Complex Formulated Into Modified-Release Tablets.
Creţeanu A; Ochiuz L; Vieriu M; Panainte AD; Ţântaru G
Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):715-9. PubMed ID: 30152660
[TBL] [Abstract][Full Text] [Related]
40. Development of inclusion complex of brinzolamide with hydroxypropyl-β-cyclodextrin.
Zhang Y; Ren K; He Z; Li H; Chen T; Lei Y; Xia S; He G; Xie Y; Zheng Y; Song X
Carbohydr Polym; 2013 Oct; 98(1):638-43. PubMed ID: 23987393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
